Core Viewpoint - Lumexa Imaging's shares experienced a slight increase during their debut on Nasdaq, leading to a market valuation of $1.76 billion for the company [1] Company Summary - Lumexa Imaging is a provider of diagnostic imaging services [1] - The company's market valuation reached $1.76 billion following its initial public offering [1]

Core Insights - Lumexa Imaging is making its public debut by raising $462.5 million in its IPO [1] - The company operates 184 diagnostic centers across 13 states [1] - Lumexa Imaging will begin trading on the Nasdaq under the ticker LMRI [1] - CEO Caitlin Zulla discussed the company's debut on Bloomberg Open Interest [1]

Core Viewpoint - Lumexa Imaging Holdings is set to raise $463 million by issuing 25 million shares at a price of $18.50 each, with a market capitalization of $1.8 billion post-listing [1] Company Overview - Lumexa Imaging Holdings is a national provider of outpatient diagnostic imaging services in the United States, operating 184 imaging centers across 13 states through wholly-owned sites and joint ventures with healthcare systems [1] - The company offers a range of advanced and routine imaging equipment, including MRI, CT, PET scans, X-rays, ultrasounds, and mammography [1] Financial Projections - For the 12 months ending September 30, 2025, Lumexa is projected to achieve sales of $1 billion [1] Listing Details - The company plans to list on NASDAQ under the ticker symbol "LMRI" [1] - The joint bookrunners for this offering include Barclays, JPMorgan, Jefferies, Deutsche Bank, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, and Raymond James [1]

Core Points - Lumexa Imaging Holdings, Inc. has announced the pricing of its initial public offering (IPO) at $18.50 per share for 25,000,000 shares of common stock [1] - The IPO includes a 30-day option for underwriters to purchase an additional 3,750,000 shares [1] - Trading is expected to commence on the Nasdaq Global Select Market under the symbol "LMRI" on December 11, 2025, with the offering closing on December 12, 2025, pending customary closing conditions [1] Company Overview - Lumexa Imaging is a nationwide provider of diagnostic imaging services, operating the second largest outpatient imaging center footprint in the United States as of September 30, 2025 [5] - The company operates 184 centers across 13 states and has eight joint venture partnerships with health systems [5]

Lumexa Imaging Holdings (LMRI) is now open for pre-IPO orders!Early Bird access is available for a limited time ahead of LMRI’s expected IPO on Dec 11, 2025.Set your limit price and get notified when trading begins. 🔔Secure your spot early 👇https://t.co/Q6C38J1EJ3 https://t.co/prDTunlTZb ...

智通财经APP获悉，美国门诊影像诊断服务提供商Lumexa Imaging Holdings于周二公布了其首次公开募 股(IPO)条款。该公司计划以每股17-20美元的价格发行2500万股股票，以筹资4.63亿美元。该公司计划 在纳斯达克上市，股票代码为"LMRI"。 据悉，Lumexa Imaging总部位于北卡罗来纳州，是一家全国性的门诊诊断影像服务提供商，通过全资运 营及与医疗系统合资合作的模式，在美国13个州运营着184家诊疗中心。该公司提供包括磁共振 (MRI)、计算机断层扫描(CT)、正电子发射断层显像(PET)、X光、超声及乳房X光检查在内的各类先进 及常规影像检查服务。该公司由Charlotte Radiology与投资机构Welsh, Carson, Anderson & Stowe于2018 年联合创立，成立之初仅拥有20家中心，后通过20次收购及41家全新门店的开设实现规模扩张。目前， 该公司已构建多元化转诊网络，合作医师覆盖2.9万余家医疗机构，总人数约10万名。数据显示，该公 司在截至2025年9月30日的12个月销售额为10亿美元。 ...

Lumexa Imaging is aiming for a valuation of more than $1.89 billion in its U.S. initial public offering, the Welsh Carson-backed said on Tuesday. ...

Donovan Jones is an IPO research specialist with 15 years of experience identifying opportunities for high quality IPOs.He also leads the investing group IPO Edge, which offers actionable information on growth stocks through first-look IPO filings, previews on upcoming IPOs, an IPO calendar for tracking what’s on the horizon, a database of U.S. IPOs, and a guide to IPO investing to walk you through the entire IPO lifecycle - from filing to listing to quiet period and lockup expiration dates. Learn moreAnaly ...